Roger Adsett, Chief Operating Officer of Insmed Inc. (INSM), executed a significant sale of company shares on August 10, 2026. Adsett sold 239,850 shares at an average price of $133.27 per share, realizing a total of approximately $31.96 million.
This transaction marks a notable insider disposition within Insmed. While insider sales can be driven by various factors such as portfolio diversification or tax planning, they do not inherently signal a negative view of the company's prospects.
Recent filings indicate other Insmed executives have also sold shares in the preceding weeks. Martina Flammer, M.D., sold shares on August 6, 2026, and William Lewis sold shares on July 23, 2026.